Gene · 2913
Papers2,242
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,242
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Astrocyte: A Foe or a Friend in Intellectual Disability-Related Diseases. | Front Synaptic Neurosci | 2022 | 35812794 | PubTator, text mining | PubMed |
| Design, Synthesis, and Characterization of [18F]mG2P026 as a High-Contrast PET Imaging Ligand for Metabotropic Glutamate Receptor 2. | J Med Chem | 2022 | 35802702 | PubTator, text mining | PubMed |
| Loss-of-Function Models of the Metabotropic Glutamate Receptor Genes Grm8a and Grm8b Display Distinct Behavioral Phenotypes in Zebrafish Larvae (Danio rerio). | Front Mol Neurosci | 2022 | 35769333 | PubTator, text mining | PubMed |
| Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search. | Mol Psychiatry | 2022 | 35768639 | PubTator, text mining | PubMed |
| Adrenal Stress Hormone Regulation of Hepatic Homeostatic Function After an Acute Ozone Exposure in Wistar-Kyoto Male Rats. | Toxicol Sci | 2022 | 35737395 | PubTator, text mining | PubMed |
| Biological Potential, Gastrointestinal Digestion, Absorption, and Bioavailability of Algae-Derived Compounds with Neuroprotective Activity: A Comprehensive Review. | Mar Drugs | 2022 | 35736165 | PubTator, text mining | PubMed |
| Inhibition of glutamate-carboxypeptidase-II in dorsolateral prefrontal cortex: potential therapeutic target for neuroinflammatory cognitive disorders. | Mol Psychiatry | 2022 | 35732693 | PubTator, text mining | PubMed |
| The Key Role of RNA Modification in Breast Cancer. | Front Cell Dev Biol | 2022 | 35721510 | PubTator, text mining | PubMed |
| Long-Term Clinical Benefit in EGFR-Mutant Lung Adenocarcinoma With Local Squamous Cell Carcinoma Transformation After EGFR TKI Resistance: A Case Report. | Front Oncol | 2022 | 35692748 | PubTator, text mining | PubMed |
| THSD7B Mutation Induces Platinum Resistance in Small Cell Lung Cancer Patients. | Drug Des Devel Ther | 2022 | 35685767 | PubTator, text mining | PubMed |
| Identification of Prognostic Biomarkers of Glioblastoma Based on Multidatabase Integration and Its Correlation with Immune-Infiltration Cells. | J Oncol | 2022 | 35685428 | PubTator, text mining | PubMed |
| Neurotransmitters-Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous System. | Int J Mol Sci | 2022 | 35682631 | PubTator, text mining | PubMed |
| New Paradigms of Old Psychedelics in Schizophrenia. | Pharmaceuticals (Basel) | 2022 | 35631466 | PubTator, text mining | PubMed |
| Structural and Functional Deviations of the Hippocampus in Schizophrenia and Schizophrenia Animal Models. | Int J Mol Sci | 2022 | 35628292 | PubTator, text mining | PubMed |
| Prognostic Neurotransmitter Receptors Genes Are Associated with Immune Response, Inflammation and Cancer Hallmarks in Brain Tumors. | Cancers (Basel) | 2022 | 35626148 | PubTator, text mining | PubMed |
| Molecular Characterization and Expression Analysis of Putative Class C (Glutamate Family) G Protein-Coupled Receptors in Ascidian Styela clava. | Biology (Basel) | 2022 | 35625509 | PubTator, text mining | PubMed |
| Advances in PSMA theranostics. | Transl Oncol | 2022 | 35597190 | PubTator, text mining | PubMed |
| Spatially resolved transcriptomics provide a new method for cancer research. | J Exp Clin Cancer Res | 2022 | 35590346 | PubTator, text mining | PubMed |
| Pilot study evaluating everolimus molecular mechanisms in tuberous sclerosis complex and focal cortical dysplasia. | PLoS One | 2022 | 35587487 | PubTator, text mining | PubMed |
| Annotating functional effects of non-coding variants in neuropsychiatric cell types by deep transfer learning. | PLoS Comput Biol | 2022 | 35576194 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2913/papers?page=14